U.S. Renewable Energy Stock News

NYSE:RL
NYSE:RLLuxury

Ralph Lauren (RL) Stock After 49% Yearly Rally Is There Still Upside Potential

Wondering if Ralph Lauren at US$393.30 is still offering value after a strong run, or if most of the upside is already reflected in the price. The stock has posted returns of 7.2% over the past week, 16.7% over the past month, 8.5% year to date and 48.9% over the past year, which naturally raises questions about growth potential and how risk is now being priced in. Recent attention on Ralph Lauren has focused on how the brand is positioned in the higher end of consumer spending and how...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

GE HealthCare (GEHC) Stock After 22% Year-To-Date Slide Is There Value Now

If you are wondering whether GE HealthCare Technologies' current share price offers value, it helps to start by looking at how the stock has actually been trading and how that lines up with its fundamentals. The stock last closed at US$64.51, with returns of 1.1% over the past week and 3.6% over the past month, while being down 22.1% year to date and 11.6% over the past year. Recent news coverage has focused on GE HealthCare Technologies as a standalone medical equipment company and how...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC the metals (TMC) Is Down 14.4% After NOAA Backs Vast Seabed Mining Expansion Plan

TMC The Metals Company recently secured NOAA approval for an expanded ocean-mining application, covering a new area that may host over 1.00 billion tonnes of polymetallic nodules containing critical minerals for modern technologies. This regulatory milestone highlights how access to a large, mineral-rich seabed area is emerging as a key battleground between resource security ambitions and concerns about deep-sea ecosystem impacts. We’ll now examine how NOAA’s approval for a vastly expanded...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble (RUM) Stock After AI Compute Pivot And Northern Data Deal How Does Valuation Stack Up

Rumble (RUM) is shifting its focus toward AI compute, securing over 85% of Northern Data AG and signing a multi-year GPU cloud capacity deal with Together AI, powered by Nvidia Blackwell B300 systems. See our latest analysis for Rumble. Against this AI compute pivot, Rumble’s 1 day share price return of 7.71% to US$7.54 comes after a 7 day share price return down 7.82% and a 30 day share price return down 4.80%, while the 90 day share price return of 41.46% points to building momentum despite...
NYSE:MCD
NYSE:MCDHospitality

McDonald's Workplace Violence Case Puts Focus On Safety And MCD Valuation

A McDonald's employee in Yuba City, California, reportedly suffered severe burns after a coworker allegedly threw hot oil on him. The incident occurred at a franchise location and has resulted in criminal charges against the alleged attacker. The case is drawing renewed attention to workplace safety and culture across McDonald's global operations. For investors watching NYSE:MCD, this incident adds a qualitative factor to consider alongside the current share price of $284.77. The stock is...
NYSE:SMR
NYSE:SMRElectrical

Is NuScale Power’s (SMR) Expanding E2 Center Network Quietly Rewriting Its Nuclear Investment Narrative?

NuScale Power recently opened its 12th Energy Exploration (E2) Center at the University of Virginia’s College at Wise, funded by the Virginia Clean Energy Innovation Bank to support nuclear education and workforce transition in southwest Virginia. This expansion of NuScale’s global E2 Center network highlights how the company is investing in training infrastructure that could underpin future adoption of its small modular reactor technology. We’ll now examine how NuScale’s growing E2 Center...
NYSE:FIG
NYSE:FIGSoftware

Figma (FIG) Stock Valuation Looks Slightly Stretched After Recent Weak Performance

Figma stock reaction and recent context Figma (FIG) has drawn investor attention after recent trading left the stock around $19.34, with short term performance mixed, including a decline over the past 3 months and year to date. See our latest analysis for Figma. With the share price at $19.34, Figma’s recent stretch has been weak, with the 7 day share price return down 14.08% and the 90 day share price return down 25.70%, pointing to fading momentum despite a flat 30 day move. If this kind of...
NYSE:CVS
NYSE:CVSHealthcare

Is CVS (CVS) Using GLP-1 Coverage And AI To Redefine Its Integrated Care Advantage?

Recently, CVS Health expanded access to GLP-1 weight management drugs by reintroducing Zepbound and easing access to Foundayo, while also ramping up AI use across pharmacy operations and mental health services. These moves highlight CVS Health's push to use advanced technology and broader drug coverage to make care more accessible and cost-effective across its integrated platform. Next, we’ll examine how the expanded GLP-1 coverage could influence CVS Health’s investment narrative and...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Why First Solar (FSLR) Is Down 13.9% After Rising Tax Credits Meet ITC Trade Scrutiny

In recent days, First Solar updated guidance to include an estimated US$2.10–US$2.19 billion in Section 45X manufacturing tax credits while facing policy and trade uncertainties, including a U.S. International Trade Commission investigation into certain solar products. At the same time, significant insider stock sales and wider geopolitical jitters have heightened investor focus on the company’s risk profile despite supportive U.S. incentives. We’ll now examine how heightened policy and...
NYSE:PRU
NYSE:PRUInsurance

Prudential Faces Japan Setback As Downgrade And Insider Selling Stir Debate

Prudential Financial (NYSE:PRU) has extended its suspension of new sales in Japan, affecting one of its key international markets. Following the extended suspension, Argus downgraded its rating on Prudential Financial, citing the Japan business challenges. Insider selling activity at Prudential Financial has increased around the time of these developments. For investors tracking NYSE:PRU, these company specific events come as the stock trades at $106.51, with the share price up 3.1% over...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Teva Extends Neuroscience Focus With Emalex Deal And Valuation Upside Potential

Teva Pharmaceutical Industries (NYSE:TEVA) has completed its acquisition of Emalex Biosciences. The deal adds ecopipam, an FDA-designated orphan drug candidate for pediatric Tourette syndrome, to Teva's late-stage neuroscience pipeline. This move aligns with Teva's Pivot to Growth strategy by increasing its focus on specialty neuroscience assets. For investors tracking NYSE:TEVA, the Emalex deal follows a period of strong stock performance, with the share price at $34.56 and the 1-year...
NYSE:WAT
NYSE:WATLife Sciences

Waters Targets Biopharma And Battery Growth With New Analytical Platforms

Waters Corporation (NYSE:WAT) has launched new BioResolve and GTxResolve Columns aimed at speeding impurity analysis in biopharmaceutical workflows. The company introduced two mass spectrometry platforms, the Cyclic IMS P20 and Xevo MRT P10, designed to increase speed, sensitivity, and multiomics capabilities. Waters also released a new Coin Cell DSC instrument focused on safer battery development and testing. Waters, known for its analytical instruments and consumables, is leaning into...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is New AI Foundry Deal Flow Altering The Investment Case For Intel’s Dual Role (INTC)?

In early June 2026, Cadence Design Systems announced an expanded multi‑year collaboration with Intel Foundry on Design Technology Co‑Optimization for Intel’s 14A process, while Hitachi and Phison separately unveiled new partnerships with Intel spanning foundry tools, quantum computing, physical AI, and enabling larger AI models on Intel-powered PCs. Taken together with a large 2028 Google TPU manufacturing order and new rackscale AI and Xeon 6+ launches, these alliances strengthen Intel’s...
NYSE:RMD
NYSE:RMDMedical Equipment

ResMed (RMD) Stock After 21% Year-To-Date Slide Is There An Opportunity Now

If you are wondering whether ResMed at around US$192 per share offers value or just more volatility, the starting point is understanding what the current price actually reflects. The stock is down 1.0% over the past week, 5.6% over the past month, and 21.4% year to date, with a 23.0% decline over the last year and 16.4% over five years, which may change how investors are thinking about both risk and opportunity. Much of the recent conversation around ResMed has focused on how the company is...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Opendoor Refocuses On U.S. AI Teams As India Exit Reshapes Risks

Opendoor Technologies is closing its India operations to centralize work in the U.S. The company plans to build AI native teams in the U.S., reshaping how it allocates global resources. This shift reflects how AI is influencing both product workflows and traditional outsourcing models. For investors tracking NasdaqGS:OPEN, this move comes as the stock trades around $4.47 and has had a very large 1 year return, while still being down 73.4% over 5 years and 26.4% year to date. The decision to...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Court Win Lifts Clover Health Star Rating And Future Revenue Potential

Clover Health Investments (NasdaqGS:CLOV) secured a court ruling requiring the Centers for Medicare & Medicaid Services to recalculate its 2026 Medicare Star Rating. The US District Court decision results in an upgrade for Clover Health's main PPO plan from 3.5 to 4.5 stars. The higher rating is expected to increase future CMS bonus payments tied to that plan's performance. The ruling reverses a prior downgrade and strengthens Clover Health's position within the Medicare Advantage...
NasdaqGS:STX
NasdaqGS:STXTech

Seagate Capacity Lock In Resets Growth Outlook And Valuation Debate

Seagate Technology Holdings (NasdaqGS:STX) has secured near-full allocation of its nearline hard drive capacity through calendar 2027. The long term commitments are backed by multi year purchase agreements with key customers. Management has raised its annual revenue growth target to at least 20% based on this contracted demand. For investors watching Seagate at a share price of $868.09, this capacity lock in comes after a period of very strong stock performance, including a return of 201.9%...
NasdaqGS:SNDK
NasdaqGS:SNDKTech

US Stock Market Today: S&P 500 Futures Rise As Energy Inflation Tests Fed Patience

The Morning Bull - US Market Morning Update Friday, Jun, 12 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up around 0.8%, as investors weigh stubborn energy driven inflation against hopes the Federal Reserve can stay patient on interest rates. May consumer prices in the US rose 0.5% in a single month, with gasoline up 7%, which keeps the pressure on household budgets and mortgage rates, now at 6.6%. At the same time, producer prices for May are expected...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum Targets Near Packaged Optics As Next AI Data Center Catalyst

Lumentum Holdings (NasdaqGS:LITE) CEO highlighted near-packaged optics, or NPO, as a major new growth driver for the company. Management indicated that NPO could become a larger opportunity than the current focus on co-packaged optics, or CPO. The CEO pointed to a potentially meaningful impact from NPO beginning in fiscal 2027 to 2028. Lumentum operates in optical and photonics technologies that sit inside the broader semiconductor and AI infrastructure supply chain. As data centers scale...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Therapeutics (AXSM) Stock Valuation Update After Strong Recent Momentum

Axsome Therapeutics (AXSM) has drawn attention after recent trading, with the stock closing at US$253.77. Investors are weighing this move against the company’s central nervous system focused drug portfolio and ongoing clinical programs. See our latest analysis for Axsome Therapeutics. The recent 3.02% 1 day share price return, along with a 62.59% 90 day share price return and 138.84% 1 year total shareholder return, points to strong momentum as investors reassess Axsome Therapeutics’ CNS...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining (HL) Stock After 27% Monthly Drop And Strong Multi‑Year Rally

If you are wondering whether Hecla Mining's current share price offers value or is running ahead of itself, the next sections break down what the numbers actually say about the stock. The share price closed at US$14.99, with the stock down 10.9% over the past week and 27.1% over the past month, although the 1-year return of 150.5% and 3-year return of 190.3% still stand out. These swings in performance have kept Hecla Mining on many investors' watchlists, as the stock has moved sharply both...
NYSE:MCB
NYSE:MCBBanks

Metropolitan Bank Holding (MCB) Stock Valuation Snapshot After Recent Momentum And Growth Expectations

Metropolitan Bank Holding (MCB) has recently drawn investor attention after its stock closed at $96.18, with performance over the past month and past 3 months prompting closer scrutiny of this regional bank. See our latest analysis for Metropolitan Bank Holding. The recent 2.44% 1 day share price return, alongside a 24.96% year to date share price return and a 47.12% 1 year total shareholder return, points to momentum that investors are weighing against the current valuation and risk...
NYSE:GPGI
NYSE:GPGITech

How GPGI’s Nevada Move and New International CCO Could Reshape GPGI (GPGI) Investors’ Outlook

In recent days, GPGI completed its conversion to a Nevada corporation, saw all 2026 annual meeting proposals approved, and CompoSecure appointed Ian Snadden as Chief Commercial Officer, International to lead global sales efforts. Taken together, the governance shift, auditor appointment and new international commercial leadership highlight a corporate focus on legal flexibility and overseas expansion at a time of operational and market challenges. Next, we’ll examine how GPGI’s move to...
NYSE:MRK
NYSE:MRKPharmaceuticals

Merck Expands Animal Health Automation And Traceability With TARGAN And Hedera

Merck Animal Health has agreed to acquire TARGAN, a poultry biodevice company focused on high speed gender identification and vaccine delivery. The company is also partnering with the Hashgraph Group to integrate Hedera powered digital product passports with its M-Trust authentication platform. Both moves expand Merck's reach into animal health automation and supply chain traceability tied to new EU transparency rules. For investors following Merck (NYSE:MRK), this news sits alongside a...